Building the foundations of successful reimbursement & market access

Disruptive Health Tech &
Personalised Medicine

Digital Medicines & Healthcare AI
Innovative biotech

Microbiome products

Start shaping product value early

Value Creation

Value is being created by making appropriate scientific and commercial choices right from the start of the development programme. Know the care environment, healthcare system and competitor situation to shape relevant product profiles.

Get started

Generate evidence that supports reimbursement and patient access

Value to Price

In the era of value-based pricing, Health Technology Assessment and growing healthcare budget pressure, your key to optimal price and broad access lies in value demonstration through appropriate evidence.

Get started

Share your vision, value proposition and access strategy

Talking Value

Fact : people are not good at communicating scientific concepts, data or complex ideas.

Prepare to share your vision, commercial and access plans for partner, investor & payer confidence.

Get started

Value in 2023 – The dynamics to anticipate in the commercial and market access environment

What is value in 2023? What are the major dynamics you want to consider as you craft your asset and commercial strategy, as well as your development programme? What are the appropriate actions to take in 2023 to convince partners and investors, and to shape an asset that shows broad value to all stakeholders?

Read on …

What is a value creation strategy?

Apersy’s expertise and approach to market access is all about value and value creation. But what exactly is this illusive concept of value? And how and why do you leverage value to achieve optimal pricing, speedy reimbursement and patient access?

Read on…

We build on our longstanding experience in Health Economics, strategic pricing & reimbursement, investor due diligence & portfolio advisory to provide a holistic picture of commercial preparedness

Behind the expertise